Gitte M Knudsen Selected Research

altanserin

3/2012	Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.
2/2011	Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.
2/2009	A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation.
9/2008	Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
4/2007	Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome.
2/2005	MR-based automatic delineation of volumes of interest in human brain PET images using probability maps.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gitte M Knudsen Research Topics

Disease

19	Schizophrenia (Dementia Praecox) 01/2022 - 02/2007
12	Mood Disorders (Mood Disorder) 12/2018 - 02/2008
9	Alzheimer Disease (Alzheimer's Disease) 03/2020 - 02/2006
7	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 06/2014
6	Mental Disorders (Mental Disorder) 11/2020 - 01/2003
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 02/2011
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 05/2013
4	Cognitive Dysfunction 01/2021 - 02/2005
4	Seasonal Affective Disorder 10/2018 - 06/2010
4	Pain (Aches) 01/2018 - 02/2009
4	Parkinsonian Disorders (Parkinsonism) 07/2013 - 02/2011
3	Epilepsy (Aura) 01/2021 - 01/2018
3	Migraine Disorders (Migraine) 01/2019 - 01/2018
3	Brain Diseases (Brain Disorder) 01/2017 - 01/2013
3	Obesity 08/2014 - 10/2012
3	Hemorrhage 01/2008 - 02/2005
2	Alcoholism (Alcohol Abuse) 01/2021 - 08/2012
2	Feeding and Eating Disorders (Eating Disorder) 08/2015 - 02/2008
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 08/2015 - 09/2005
2	Listeriosis (Listeria Infection) 04/2015 - 12/2013
2	Infections 12/2013 - 11/2010
2	Dementia (Dementias) 07/2013 - 01/2013
2	Overweight 01/2013 - 10/2012
2	Hyperphagia (Overeating) 01/2013 - 10/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2012 - 02/2008
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2010 - 10/2009
1	Sleep Deprivation 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 08/2021
1	Parkinson Disease 16 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Stroke (Strokes) 01/2018
1	Ischemic Stroke 01/2018
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 09/2015
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2015
1	Sleep Wake Disorders 08/2015
1	Foodborne Diseases 04/2015
1	Weight Gain 11/2014
1	Gambling (Pathological Gambling) 08/2013
1	Hallucinations (Hallucination) 07/2013
1	AIDS-Related Complex (ARC) 05/2013

Drug/Important Bio-Agent (IBA)

21	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2007
19	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2022 - 02/2005
10	Pharmaceutical PreparationsIBA 01/2021 - 10/2010
8	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 02/2007
8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 12/2017 - 06/2009
6	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 08/2012
6	altanserinIBA 03/2012 - 02/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
5	Serotonin ReceptorsIBA 01/2020 - 01/2003
4	Antidepressive Agents (Antidepressants)IBA 01/2022 - 10/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2008
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2020 - 09/2011
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 07/2013 - 01/2013
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2012 - 05/2008
2	Messenger RNA (mRNA)IBA 01/2022 - 05/2013
2	Hallucinogens (Psychedelics)IBA 01/2022 - 01/2019
2	LigandsIBA 01/2021 - 02/2011
2	pimavanserinIBA 01/2020 - 03/2015
2	SB 207145IBA 01/2019 - 01/2018
2	5-HT4 Serotonin ReceptorsIBA 01/2019 - 01/2018
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2015 - 06/2009
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2014 - 02/2011
2	Dopamine (Intropin)FDA LinkGeneric 01/2013 - 02/2011
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 03/2012 - 01/2011
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2008 - 01/2007
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Psilocybin (Psilocibin)IBA 01/2019
1	5-HT1B Serotonin ReceptorIBA 01/2018
1	5- methyl- 8- (4- methyl- piperazin- 1- yl)- 4- oxo- 4H- chromene- 2- carboxylic acid (4-morpholin-4-yl-phenyl)amideIBA 01/2018
1	CarbohydratesIBA 01/2017
1	SteroidsIBA 03/2016
1	Ligand-Gated Ion ChannelsIBA 09/2015
1	6- chloro- 2- (4'- iodophenyl)- 3- (N,N- diethyl)imidazo(1,2- a)pyridine- 3- acetamideIBA 09/2015
1	Amino Acids FDA Link 09/2015
1	pyridineIBA 09/2015
1	acetamideIBA 09/2015
1	GadoliniumIBA 09/2015
1	Bacteriocins (Lantibiotics)IBA 04/2015
1	Opioid Analgesics (Opioids)IBA 11/2014
1	DiprenorphineIBA 11/2014
1	VortioxetineIBA 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013
1	4-iodo-2,5-dimethoxyphenylisopropylamine (DOI-P)IBA 05/2013
1	Phencyclidine (Angel Dust)IBA 05/2013
1	Early Growth Response Protein 2IBA 05/2013
1	Lysergic Acid Diethylamide (LSD)IBA 05/2013
1	norquetiapineIBA 04/2013
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2013

Therapy/Procedure

2	Lasers (Laser) 01/2008 - 02/2005
1	Resuscitation 08/2021
1	Precision Medicine 01/2020
1	Thrombectomy 01/2018
1	Therapeutics 01/2018